This was a randomized , open-label , multicenter trial comparing the efficacy and safety of intravenous palonosetron 0.075 mg and intravenous ondansetron 4mg in patients experiencing PONV following laparoscopic abdominal or gynecological surgery despite prophylactic ondansetron .